Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2020

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity

The following table presents certain information related to the activity of our non-vested stock option grants:

	Number of Stock Options	Weighted Average Exercise Prices		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Outstanding as of December 31, 2019	207,069	$	18.69	9.00	$	—
Granted	221,541	8.77		—	—
Less: Forfeited	234,472	12.76		—	—
Less: Expired	32,098	18.87		—	—
Less: Exercised	—	—		—	—
Outstanding as of September 30, 2020	162,040	$	13.67	8.03	$	—
Vested as of September 30, 2020	73,956	$	18.81	2.69	$	—
Exercisable as of September 30, 2020	41,858	$	18.77	4.76	$	—

Schedule of Nonvested Share Activity

The following table presents certain information related to the activity of our non-vested common stock grants:

	Number of Restricted Shares	Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2019	214,495	$	17.49
Granted (1)	384,572	9.35
Less: Forfeited	232,323	12.61
Less: Vested (1)	109,267	16.63
Outstanding as of September 30, 2020	257,477	$	10.10

Share-based Payment Arrangement, Activity

The following table presents our total stock-based compensation expense:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Employee stock-based compensation expense
Pre-tax (1)	$	108	$	536	$	582	$	1,482
Post-tax (2)	86		424		460		1,171
Director stock-based compensation expense
Pre-tax (1)	99		178		406		810
Post-tax (2)	78		141		321		640

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following weighted-average assumptions were used to value the stock options granted:

	2020
Expected annual dividend yield	1.70	%
Expected volatility	41.59	%
Risk-free interest rate	2.35	%
Expected term	6 Years